Glenmark Pharmaceuticals has informed that it has attached media release on 2nd August 2021 titled ‘Glenmark inks agreement with Canadian biotech SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID?19 treatment in India and other Asian markets’.
The above information is a part of company’s filings submitted to BSE.